Amalia Kimber
Obstetrics & Gynecology · Santa Rosa, CANPI 1326344268
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Organon at 50.4% of the total. Reporting peaked in 2022 at $3,999 and has fallen 82.4% since, to $704 in 2025. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $39.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$4K
- AbbVie$892
- Mayne Pharma Commercial LLC$728
- Hologic Sales And Service, LLC$462
- Astellas Pharma US Inc$311
- Therapeuticsmd, Inc.$175
- plus $979 from 17 others
What the payments were for
- Speaking & faculty fees$3,21345%
- Food & beverage$3,77353%
- Education$1582%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 22 | $3,598 |
| AbbVie | 33 | $892 |
| Mayne Pharma Commercial LLC | 54 | $728 |
| Hologic Sales And Service, LLC | 10 | $462 |
| Astellas Pharma US Inc | 8 | $311 |
| Therapeuticsmd, Inc. | 11 | $175 |
| Biohaven Pharmaceuticals, Inc. | 5 | $119 |
| Myovant Sciences Inc. | 5 | $111 |
| Biogen | 4 | $101 |
| Pfizer | 4 | $93 |
| Avion Pharmaceuticals | 6 | $89 |
| Vertex | 3 | $80 |
| Evofem Biosciences, Inc. | 3 | $60 |
| Millicent US Inc | 3 | $58 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Merck | 2 | $43 |
| Shield Therapeutics Inc | 1 | $33 |
| Sage Therapeutics, LLC | 1 | $30 |
| Revance Therapeutics, Inc. | 1 | $30 |
| Avanos Medical | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,143 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Other obstetrics & gynecology in Santa Rosa
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.